Is Medicube Zero Pore Pad 2.0 Safe During Pregnancy? (Updated 2026 Guide)

Updated March 12, 2026

F Avoid

Medicube Zero Pore Pad 2.0

Medicube

Safe ingredients
22
Likely safe ingredients
2
Caution ingredients
2
Avoid ingredients
1
Total ingredients
27

No, Medicube Zero Pore Pad 2.0 is not recommended during pregnancy and received an F grade. It contains salix alba bark extract, a source of salicin that is flagged to avoid, as well as salicylic acid and other ingredients requiring caution.

Do not use during pregnancy. If you've already used it, don't worry - we're all learning. If it was heavy usage or large doses, please contact your OBGYN or midwife.

Pregnancy Safe is 100% independent and research driven. No companies pay to promote or sponsor products.

What Ingredients Are in Medicube Zero Pore Pad 2.0?

Medicube Zero Pore Pad 2.0 has 27 ingredients. We flagged 1 to avoid and 2 to use with caution.

citrus aurantium dulcis fruit extract

CAUTION

Citrus aurantium dulcis fruit extract is a citrus fruit used in supplements for weight loss. Citrus aurantium dulcis fruit extract requires caution because high dose exposure may raise blood pressure and heart rate.

salicylic acid

CAUTION

Salicylic acid is a beta hydroxy acid for acne treatment. Salicylic acid requires caution during pregnancy because high concentrations can produce aspirin like effects, particularly later in pregnancy.

salix alba bark extract

AVOID

Salix alba bark extract is an herbal remedy containing salicin. Salix alba bark extract should be avoided during pregnancy because it contains salicin and salicylates can cross the placenta and increase bleeding risk.

propanediol

LIKELY SAFE

Propanediol is a solvent and preservative in foods and cosmetics. Propanediol is considered likely safe at typical cosmetic exposures, although pregnancy may reduce the body's ability to process it.

tocopherol

LIKELY SAFE

Tocopherol is a fat soluble antioxidant Vitamin commonly found in prenatal supplements and vegetable oils. Tocopherol is considered likely safe in typical cosmetic use, while excessive exposure during early pregnancy may present concerns.

butylene glycol

SAFE

Butylene glycol is a versatile, colorless, and odorless solvent and humectant commonly used in skincare and cosmetic formulations to help retain moisture and improve product texture. Butylene glycol is listed as safe for pregnancy in this formula and functions as a moisturizing solvent.

centella asiatica extract

SAFE

Centella asiatica extract is a natural plant extract known for its soothing, healing, and anti aging properties, commonly used in skincare products. Centella asiatica extract is listed as a pregnancy safe, soothing botanical in this formula.

chamaecyparis obtusa leaf extract

SAFE

Chamaecyparis obtusa leaf extract is a natural botanical ingredient known for its antioxidant, anti inflammatory, and skin soothing properties. Chamaecyparis obtusa leaf extract is listed as safe for pregnancy in this formula.

Answering Your Questions

How much Medicube Zero Pore Pad 2.0 is safe during pregnancy?

The safest amount during pregnancy is none because this product contains salix alba bark extract. If you have already used it, stop using it and ask your prenatal healthcare professional if you are concerned.

Can you use Medicube Zero Pore Pad 2.0 daily while pregnant?

Avoid using this product throughout pregnancy unless your healthcare professional specifically advises otherwise. Choose a pregnancy compatible alternative without willow bark extract or other salicylates for regular skincare.

Why did Medicube Zero Pore Pad 2.0 receive an F grade?

It received an F because it contains salix alba bark extract, an ingredient flagged to avoid during pregnancy. Willow bark contains salicin, and salicylate exposure raises pregnancy related bleeding concerns.

Does Medicube Zero Pore Pad 2.0 contain salicylic acid?

Yes. Salicylic acid appears in the ingredient analysis, along with salix alba bark extract, another source of salicylate related concern.

Can I use Medicube Zero Pore Pad 2.0 while breastfeeding?

Breastfeeding exposure differs from pregnancy exposure, but this formula still contains salicylic acid and willow bark extract. Ask your healthcare professional before use, and do not apply it on or near the nipple where an infant could ingest it.

What can I use instead during pregnancy?

Look for a gentle, pregnancy compatible Toner pad or hydrating treatment that does not contain willow bark extract, salicylic acid, or other salicylates. If your skin is reactive, a fragrance free formula without essential oils may also be a better choice.

Can Medicube Zero Pore Pad 2.0 cause side effects?

Exfoliating ingredients such as salicylic acid can cause dryness, redness, flaking, or irritation, especially with frequent use or on sensitive skin. The botanical and essential oil ingredients may also be irritating for some people.

Is Medicube Zero Pore Pad 2.0 suitable for acne prone skin?

Salicylic acid can exfoliate pores, but the formula also contains botanical extracts and eucalyptus oil that may not suit reactive or acne prone skin. During pregnancy, its F grade and willow bark content make a pregnancy compatible alternative the better choice.

How Does Medicube Zero Pore Pad 2.0 Compare to Other Skin Care Pads?

We graded 1 Skin Care Pads for pregnancy safety. Here's how they stack up:

A
0%
B
0%
C
0%
D
0%
F
100%

Medicube Zero Pore Pad 2.0 earns a F grade, placing it among the majority of Skin Care Pads. Only 0% of products in this category get an A grade, so it pays to choose carefully.

How Do We Score Products for Pregnancy Safety?

We analyze each product's ingredients and category to flag known risks and provide cautionary notices for general category safety concerns.

People Also Checked

References

  1. https://www.rxlist.com/supplements/bitter_orange.htm
  2. https://www.scielo.br/j/aabc/a/pkCgwkXxd4SWdKNSQnBhyCh/
  3. https://pmc.ncbi.nlm.nih.gov/articles/PMC3129698/
  4. https://www.nutritionaloutlook.com/view/fda funds bitter orange toxicology study
  5. https://pmc.ncbi.nlm.nih.gov/articles/PMC4177623/